Jonasova, A., & Minarik, L. (2024). FIRST SINGLE-CENTER EXPERIENCE WITH LUSPATERCEPT THERAPY IN LOW-RISK MYELODYSPLASTIC SYNDROME (LR-MDS) PATIENTS WITH TRANSFUSION DEPENDENCE REFRACTORY TO ERYTHROPOIETIN THERAPY. Elsevier.
Чикаго-гийн эшлэл (17 дахь хэвлэлт)Jonasova, A., ба L. Minarik. FIRST SINGLE-CENTER EXPERIENCE WITH LUSPATERCEPT THERAPY IN LOW-RISK MYELODYSPLASTIC SYNDROME (LR-MDS) PATIENTS WITH TRANSFUSION DEPENDENCE REFRACTORY TO ERYTHROPOIETIN THERAPY. Elsevier, 2024.
MLA -ийн эшлэл (9 дэх хэвлэлт)Jonasova, A., ба L. Minarik. FIRST SINGLE-CENTER EXPERIENCE WITH LUSPATERCEPT THERAPY IN LOW-RISK MYELODYSPLASTIC SYNDROME (LR-MDS) PATIENTS WITH TRANSFUSION DEPENDENCE REFRACTORY TO ERYTHROPOIETIN THERAPY. Elsevier, 2024.
Анхааруулга: Эдгээр ишлэлүүд үргэлж 100% үнэн зөв биш байж магадгүй.